Regulate Metabolism at the Microbiome Level

Symbiota™ 901 is an advanced multi-strain postbiotic ingredient engineered to target the gut-metabolic axis. By utilizing precision symbiotic fermentation, it delivers bioactive metabolites that naturally stimulate metabolic signaling pathways, offering a cutting-edge solution for glucose control and insulin sensitivity.

Core Mechanisms & Clinical Highlights

• Natural GLP-1 Stimulation: Clinical data demonstrates a significant increase in GLP-1 secretion compared to the control group, effectively supporting glucose homeostasis and appetite regulation.
• HbA1c Stabilization: Proven efficacy as a complementary metabolic strategy in human trials, where 75% of metformin-resistant individuals successfully showed stable or reduced HbA1c levels.
• Targeted IMP Reduction: Formulated to regulate IMP-related metabolic pathways, shown to decrease Imidazole Propionate (IMP) by 52%—a critical microbial marker linked to insulin resistance—making it the premier metabiotic ingredient for metabolic syndrome management.